Reactive Oxygen Species-Manipulated Drug Release from a Smart Envelope-Type Mesoporous Titanium Nanovehicle for Tumor Sonodynamic-Chemotherapy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Despite advances in drug delivery systems (DDSs), the stimuli-responsive controlled release DDSs with high spatial/temporal resolution are still the best choice. Herein, a novel type of envelope-type mesoporous titanium dioxide nanoparticle (MTN) was developed for one-demand drug delivery platform. Docetaxel (DTX) was loaded in the pores of MTN with a high drug loading efficiency (∼26%). Then β-cyclodextrin (β-CD, a bulky gatekeeper) was attached to the outer surface of MTN via a reactive oxygen species (ROS) sensitive linker to block the pores (MTN@DTX-CD). MTN@DTX-CD could entrap the DTX in the pores and allow the rapid release until a focused ultrasound (US) emerged. A large number of ROS were generated by MTN under US radiation, leading to the cleavage of the ROS-sensitive linker; thus, DTX could be released rapidly since the gatekeepers (β-CD) were detached. Besides, the generation of ROS could also be used for tumor-specific sonodynamic therapy (SDT). Studies have shown the feasibility of MTN@DTX-CD for US-triggered DTX release and sonodynamic-chemotherapy. In the in vitro and in vivo studies, by integrating SDT and chemotherapy into one system, MTN@DTX-CD showed excellent antitumor efficacy. More importantly, this novel DDS significantly decreased the side effects of DTX by avoiding the spleen and hematologic toxicity to tumor-bearing mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesoporous silica nanoparticles in drug delivery and biomedical applications
Wang, Y., Zhao, Q., Han, N., Bai, L., Li, J., Liu, J., Che, E., Hu, L., Zhang, Q., Jiang, T., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.09.014 · Cited by 1,192
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
Li, Q., Liu, Q., Wang, P., Feng, X., Wang, H., & Wang, X. (2014) · Ultrasonics · doi:10.1016/j.ultras.2013.11.009 · Cited by 63
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Self-citationQian, X., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201602012 · Cited by 882
Recent Advances in Nanomaterial‐Assisted Combinational Sonodynamic Cancer Therapy
Liang, S., Deng, X., Ma, P., Cheng, Z., & Lin, J. (2020) · Advanced Materials · doi:10.1002/adma.202003214 · Cited by 598
Ultrasound‐Activated Sensitizers and Applications
Lin, X., Song, J., Chen, X., & Yang, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201906823 · Cited by 501
Han, X., Huang, J., Jing, X., Yang, D., Lin, H., Wang, Z., Li, P., & Chen, Y. (2018) · ACS Nano · doi:10.1021/acsnano.8b00899 · Cited by 437
Near-infrared phosphorescent carbon dots for sonodynamic precision tumor therapy
Geng, B., Hu, J., Li, Y., Feng, S., Pan, D., Feng, L., & Shen, L. (2022) · Nature Communications · doi:10.1038/s41467-022-33474-8 · Cited by 405
Liang, S., Deng, X., Xu, G., Xiao, X., Wang, M., Guo, X., Ma, P., Cheng, Z., Zhang, D., & Lin, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908598 · Cited by 324
Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics
Pan, X., Wang, H., Wang, S., Sun, X., Wang, L., Wang, W., Shen, H., & Liu, H. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9262-x · Cited by 302
Self-citationAn, D., Fu, J., Zhang, B., Xie, N., Nie, G., Ågren, H., Qiu, M., & Zhang, H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202101625 · Cited by 261
Sonodynamic Therapy: Advances and Challenges in Clinical Translation
Lafond, M., Yoshizawa, S., & Umemura, S. (2019) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14733 · Cited by 164
Design and application of inorganic nanoparticles for sonodynamic cancer therapy
Sun, L., Wang, P., Zhang, J., Sun, Y., Sun, S., Xu, M., Zhang, L., Wang, S., Liang, X., & Cui, L. (2021) · Biomaterials Science · doi:10.1039/d0bm01875a · Cited by 115
Current status and future perspectives of sonodynamic therapy in glioma treatment.
Wang, X., Jia, Y., Wang, P., Liu, Q., & Zheng, H. (2017) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2017.02.020 · Cited by 86
Wang, G., Wu, W., Zhu, J.-J., & Peng, D. (2021) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2021.105781 · Cited by 61
“Moreover, the agglomeration of NPs prevents the separation of electron-hole pairs from the energy band, resulting in a further decrease in ROS yield [86].”
BackgroundZuo, S., Zhang, Y., Wang, Z., & Wang, J. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s348618 · Cited by 41
“Additionally, mTNPs possess an easily modified surface and unique mesopores, which endows them with excellent drug loading ability.(29,30) Triphenyl phosphonium (TPP), having three phenyl groups, is a common mitochondria-targeting ligand with positive charge to attract negatively charged mitochondria.”
Background
Metadata
- Authors
- Shi, J., Chen, Z., Wang, B., Wang, L., Lu, T., & Zhang, Z.
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-12-21
- Volume
- 7
- Issue
- 51
- Pages
- 28554-28565
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- OpenAlex
- W2317079887
- Cited by
- 126
- References
- 3
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.